Sotalol hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for sotalol hydrochloride and what is the scope of patent protection?
Sotalol hydrochloride
is the generic ingredient in five branded drugs marketed by Altathera Pharms Llc, Azurity, Legacy Pharma, Aiping Pharm Inc, Apotex, Aurobindo Pharma Usa, Beximco Pharms Usa, Epic Pharma Llc, Impax Pharms, Natco Pharma Usa, Oxford Pharms, Rising, Sun Pharm Industries, Teva, Upsher Smith Labs, and Watson Labs, and is included in twenty-one NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.Sotalol hydrochloride has one patent family member in one country.
There are seven drug master file entries for sotalol hydrochloride. Twenty-three suppliers are listed for this compound.
Summary for sotalol hydrochloride
International Patents: | 1 |
US Patents: | 8 |
Tradenames: | 5 |
Applicants: | 16 |
NDAs: | 21 |
Drug Master File Entries: | 7 |
Finished Product Suppliers / Packagers: | 23 |
Raw Ingredient (Bulk) Api Vendors: | 110 |
Clinical Trials: | 44 |
Patent Applications: | 5,105 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for sotalol hydrochloride |
What excipients (inactive ingredients) are in sotalol hydrochloride? | sotalol hydrochloride excipients list |
DailyMed Link: | sotalol hydrochloride at DailyMed |
Recent Clinical Trials for sotalol hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rush University Medical Center | N/A |
HagaZiekenhuis | Phase 2/Phase 3 |
Abant Izzet Baysal University | N/A |
Pharmacology for sotalol hydrochloride
Drug Class | Antiarrhythmic |
Mechanism of Action | Adrenergic beta-Antagonists |
Physiological Effect | Cardiac Rhythm Alteration |
Medical Subject Heading (MeSH) Categories for sotalol hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for sotalol hydrochloride
US Patents and Regulatory Information for sotalol hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azurity | SOTYLIZE | sotalol hydrochloride | SOLUTION;ORAL | 205108-001 | Oct 22, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Sun Pharm Industries | SOTALOL HYDROCHLORIDE | sotalol hydrochloride | TABLET;ORAL | 075515-002 | Oct 15, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Legacy Pharma | BETAPACE | sotalol hydrochloride | TABLET;ORAL | 019865-004 | Oct 30, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Legacy Pharma | BETAPACE AF | sotalol hydrochloride | TABLET;ORAL | 021151-006 | Apr 2, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma Usa | SOTALOL HYDROCHLORIDE | sotalol hydrochloride | TABLET;ORAL | 077616-001 | Feb 7, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for sotalol hydrochloride
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 2015153762 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.